Cognitive / neuro
Dihexa
Preclinical (animal)PNB-0408 · Angiotensin-IV-derived synaptogenic compound
Potent experimental synapse-forming cognitive compound.
What it is
A small molecule derived from angiotensin IV, designed to be orally active and brain-penetrant, investigated for powerful synaptogenesis.
How it works
Acts via the hepatocyte growth factor (HGF)/c-Met system to promote synapse and dendritic-spine formation.
Studied for
Cognitive enhancement, Alzheimer's/dementia models, memory.
Regulatory status
Not approved; research chemical.
Safety
Human safety unknown; potent growth/HGF-c-Met signaling raises theoretical proliferation concerns.
What the community reports about Dihexa
Aggregated from real community discussions across social platforms and forums. Anecdotal and self-reported — not causal, not medical advice.
Dihexa is an orally active angiotensin IV analog and putative HGF/c-Met agonist marketed as a synaptogenic nootropic, but its foundational research has been challenged as fraudulent and the corpus consensus is that it is the most experimental, most cancer-risk-laden compound in mainstream peptide discussion.
- Strong cognitive-restoration claims — 'returns capabilities to your historical peak'
Aggregated from public discussions and community forums, synthesized into themes and counts. Anecdotal and self-reported — not causal, not evidence a compound is safe or effective, not medical advice, and not a recommendation to use. No dosing shown.
Educational information only — not medical advice, and not a recommendation to use any compound. Many peptides here are not approved for human use; legal status and evidence quality vary and are noted above. This page contains no dosing information. Consult a qualified clinician before making any health decision.